A Quick Look at Today's Ratings for Northrop Grumman(NOC.US), With a Forecast Between $470.57 to $605
A Quick Look at Today's Ratings for RTX Corp(RTX.US), With a Forecast Between $115 to $142
Oppenheimer Maintains Nasdaq(NDAQ.US) With Buy Rating, Raises Target Price to $75
Barclays Maintains Nasdaq(NDAQ.US) With Buy Rating, Raises Target Price to $77
Truist Financial Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Announces Target Price $62
RTX Price Target Raised to $142.00/Share From $115.00 by TD Cowen
Cantor Fitzgerald Raises Price Target on Bristol-Myers Squibb to $50 From $45
Citigroup Adjusts Price Target on Nasdaq to $70 From $63, Neutral Rating Maintained
UBS Adjusts RTX Price Target to $117 From $107, Maintains Neutral Rating
A Quick Look at Today's Ratings for RTX Corp(RTX.US), With a Forecast Between $115 to $142
A Quick Look at Today's Ratings for Northrop Grumman(NOC.US), With a Forecast Between $467 to $521
A Quick Look at Today's Ratings for Nasdaq(NDAQ.US), With a Forecast Between $73 to $78
Northrop Grumman Price Target Raised to $509.00/Share From $467.00 by Wells Fargo
Seaport Global Keeps Their Buy Rating on Northrop Grumman (NOC)
RTX Price Target Raised to $140.00/Share From $119.00 by Susquehanna
Northrop Grumman Analyst Ratings
Nasdaq Price Target Raised to $78.00/Share From $76.00 by Keefe, Bruyette & Woods
Wolfe Adjusts Price Target on Northrop Grumman to $425 From $420
Oppenheimer Maintains Pool Corp(POOL.US) With Buy Rating, Raises Target Price to $380
Nasdaq Analyst Ratings